NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

Healthcare > Biotechnology

Buy SLS

*Your capital is at risk

$8.23

-0.81 (-8.96%)

At Close: Jun 05, 2026

Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
PantherTS	Jul 29, 2019	$0.153 -98.09%	$0.160	X	95.63%
PantherTS	Jul 18, 2019	$0.435 -93.31%	$0.131	X	0.00%
JS Pro	Jul 8, 2019	$0.253 -97.47%	$0.196	X	70.65%
CoffeeNtrees @CoffeeNtrees.114765	Jul 8, 2019	$0.250 -97.50%	$0.196	X	72.19%
AGsmash	Jul 8, 2019	$0.374 -96.26%	$0.196	X	8.79%
JS Pro	Jul 5, 2019	$0.212 -98.16%	$0.232	X	91.26%
JS Pro	Jul 3, 2019	$0.149 -98.51%	$0.202	X	73.95%
JS Pro	Jun 18, 2019	$0.168 -97.76%	$0.154	X	90.77%
JS Pro	Jun 17, 2019	$0.230 -97.13%	$0.157	X	53.50%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SELLAS LIFE SCIENCES GROUP INC.

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by